Journal of Gastroenterology

, Volume 45, Issue 1, pp 24–29 | Cite as

Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn’s disease

  • Takayuki YamamotoEmail author
  • Maki Nakahigashi
  • Satoru Umegae
  • Koichi Matsumoto
Original Article—Alimentary Tract



Hitherto, the efficacy of enteral nutrition (EN) on clinical outcomes during biological maintenance therapy in Crohn’s disease (CD) has not been investigated. This prospective study was to assess the efficacy of EN on the maintenance rate of clinical remission in patients with quiescent CD receiving infliximab as maintenance therapy.


Fifty-six patients who achieved clinical remission with infliximab induction therapy received infliximab as maintenance therapy (5 mg/kg, every 8 weeks). Thirty-two of the 56 patients received concomitant EN: elemental diet infusion during night-time and a low fat diet during daytime (EN group), while the remaining 24 patients received neither nutritional therapy nor food restriction (non-EN group). All patients were followed for 56 weeks; CD activity index (CDAI) was assessed and CDAI < 150 was defined as clinical remission.


During the 56-week observation, the mean CDAI was not significantly different between the 2 groups. Seven patients in the EN group ceased EN therapy because they maintained complete remission. On an intention-to-treat basis, 25 patients in the EN group (78%) and 16 patients in the non-EN group (67%) remained in clinical remission during the 56-week observation (P = 0.51).


The outcomes of this prospective study showed that concomitant EN during infliximab maintenance therapy does not significantly increase the maintenance rate of clinical remission in patients with CD.


Crohn’s disease Elemental diet Enteral nutrition Infliximab Clinical remission 


Conflict of interest statement



  1. 1.
    Akobeng AK. Review article: the evidence base for interventions used to maintain remission in Crohn’s disease. Aliment Pharmacol Ther. 2008;27:11–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Behm BW, Bickston SJ. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 2008;(1):CD006893.Google Scholar
  3. 3.
    Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease—epidemiology and treatment. Aliment Pharmacol Ther. 2009;30:99–112.CrossRefPubMedGoogle Scholar
  4. 4.
    Verma S, Kirkwood B, Brown S, Giaffer MH. Oral nutritional supplementation is effective in the maintenance of remission in Crohn’s disease. Dig Liver Dis. 2000;32:769–74.CrossRefPubMedGoogle Scholar
  5. 5.
    Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Takahashi S, Iwabuchi M, et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24:1333–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther. 2007;25:67–72.PubMedCrossRefGoogle Scholar
  7. 7.
    Yamamoto T, Nakahigashi M, Saniabadi AR, Iwata T, Maruyama Y, Umegae S, et al. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn’s disease: a prospective study. Inflamm Bowel Dis. 2007;13:1493–501.CrossRefPubMedGoogle Scholar
  8. 8.
    Tanaka T, Takahama K, Kimura T, Mizuno T, Nagasaka M, Iwata K, et al. Effect of concurrent elemental diet on infliximab treatment for Crohn’s disease. J Gastroenterol Hepatol. 2006;21:1143–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–44.PubMedGoogle Scholar
  10. 10.
    Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K. Enteral nutrition for the maintenance of remission in Crohn’s disease: a systematic review. Eur J Gastroenterol Hepatol 2009 (Epub ahead of print).Google Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Takayuki Yamamoto
    • 1
    Email author
  • Maki Nakahigashi
    • 1
  • Satoru Umegae
    • 1
  • Koichi Matsumoto
    • 1
  1. 1.Inflammatory Bowel Disease CenterYokkaichi Social Insurance HospitalYokkaichiJapan

Personalised recommendations